McGuire W L
Hosp Pract. 1980 Apr;15(4):83-8. doi: 10.1080/21548331.1980.11946586.
Endocrine therapy can significantly prolong life in about a third of patients with advanced mammary carcinoma, but until recently it has been impossible to predict which ones. Assays for receptors specific for estrogen and progesterone have made the predictive process more accurate, and antiestrogens are providing the basis for a new approach to therapy. Clinical applications are outlined.
内分泌疗法可显著延长约三分之一晚期乳腺癌患者的生命，但直到最近仍无法预测哪些患者适用该疗法。雌激素和孕激素特异性受体检测使预测过程更加准确，抗雌激素药物为一种新的治疗方法提供了依据。本文概述了其临床应用。
